Michael Bethune
14Patents
4h-index
26Co-inventors
56Inventor score
Filing activity: Oct 19, 2004 → Dec 21, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7320788B2 | Enzyme treatment of foodstuffs for Celiac Sprue | Human Necessities | 42 | Expired |
| US7628985B2 | Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis | Emerging Cross-Sectional Technologies | 24 | Expired |
| US8796201B2 | Enzyme treatment of foodstuffs for celiac sprue | Human Necessities | 10 | Active |
| US9884075B2 | Domain-swap T cell receptors | Human Necessities | 5 | Active |
| US8778338B2 | Combination enzyme therapy for digestion of dietary gluten | Human Necessities | 1 | Active |
| US11125756B2 | Ligand discovery for T cell receptors | Physics | 1 | Active |
| US11846639B2 | Ligand discovery for T cell receptors | Physics | 0 | Active |
| US10816554B2 | Ligand discovery for T cell receptors | Physics | 0 | Active |
| US8535946B2 | Biomarker to measure drug efficacy in enteropathic disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US12215347B2 | Chimeric antigen receptors with enhanced signaling and activities and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11125755B2 | Ligand discovery for T cell receptors | Physics | 0 | Active |
| US12066430B2 | Trogocytosis mediated epitope discovery methods | Physics | 0 | Active |
| US12221465B2 | Signaling and antigen-presenting bifunctional receptors (SABR) | Physics | 0 | Active |
| US12404315B2 | Protease-activating CD45-gate CAR | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.